Ephiós AB was originally founded in 2001 in Rejmyre, Sweden.

Our aim is to develop electrophysiology devices for testing retinal function of the eye.

Market users include; Ophthalmology, Neurophysiology, Intensive Care, Children Clinics, Geriatrics, Human doctors, Veterinarians, Clinical work, Research, Pharmaceutical Industry and Universities are found in Sweden, Finland, France, Belgium, USA, Canada, Taiwan and Russia.

Pilot testing on humans is currently performed in Sweden, Europe, Russia, USA, Canada, Taiwan, China and Japan.

Today we have worldwide distribution partners in Europe, Russia, USA and Asia.

Concept

Benefits of our concept are many; de-dramatisation of existing applications and opening of new areas previously not possible in the field, in and out of the clinic. Our devices allows for cost-effective screening of patients providing users time and money savings. Tests can easily be done on-the-fly without prior time-booking or other arrangements. The test itself is merciful and non-dramatic for the patient. Several patients can be tested in a session. The list goes on.

For further information please contact us.